SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001735276-24-000017
Filing Date
2024-02-29
Accepted
2024-02-29 16:17:12
Documents
1
Period of Report
2024-02-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 16640
  Complete submission text file 0001735276-24-000017.txt   18252
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SQZ BIOTECHNOLOGIES COMPANY 200 ARSENAL YARDS BOULEVARD, SUITE 210 WATERTOWN MA 02472
Business Address
Garg Pushkal (Reporting) CIK: 0001829252 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36407 | Film No.: 24703901